Litigation Details for Exelixis, Inc. v. MSN Laboratories Private Limited (D. Del. 2020)
✉ Email this page to a colleague
Exelixis, Inc. v. MSN Laboratories Private Limited (D. Del. 2020)
Docket | ⤷ Sign Up | Date Filed | 2020-05-11 |
Court | District Court, D. Delaware | Date Terminated | 2023-01-29 |
Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
Jury Demand | None | Referred To | Sherry R. Fallon |
Parties | MSN LABORATORIES PRIVATE LIMITED | ||
Patents | 7,579,473; 8,497,284 | ||
Attorneys | Dominick T. Gattuso | ||
Firms | Heyman Enerio Gattuso & Hirzel LLP | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Exelixis, Inc. v. MSN Laboratories Private Limited
Details for Exelixis, Inc. v. MSN Laboratories Private Limited (D. Del. 2020)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2020-08-31 | 26 | Notice of Service | Initial Invalidity Contentions for U.S. Patent Nos. 7,579,473 AND 8,497,284 filed by MSN Laboratories …2020 30 January 2023 1:20-cv-00633 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
2020-05-11 | 4 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,579,473 B2 ;8,497,284 B2. (…2020 30 January 2023 1:20-cv-00633 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |